Article PDF
References
Muller JE, Stone PH, Turi ZG, et al: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315–1322.
Pickering TG, Levenstein M, Walmsley P, for the Hypertension and Lipid Trial Study Group: Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure: results of the HALT Study. Am J Hypertens 1994; 7: 844–847.
Kario K, Pickering TG, Hoshide S, et al: Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004; 17: 668–675.
Yang S, Zhang L : Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004; 2: 1–12.
Dodt C, Breckling U, Derad I, Fehm HL, Born J : Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30: 71–76.
Portaluppi F, Bagni B, degli Uberti E, et al: Circadian rhythms of atrial natriuretic peptide, rennin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens 1990; 8: 85–95.
Verdecchia P : Pre-clinical and clinical experience of telmisartan in cardiac remodelling. J Int Med Res 2005; 33 ( Suppl 1): 12A–20A.
Peixoto AJ, White WB : Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int 2007; 71: 855–860.
Millar-Craig MW, Bishop CN, Raftery EB : Circadian variation of blood-pressure. Lancet 1978; 1: 795–797.
Metoki H, Ohkubo T, Kikuya M, et al: Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47: 149–154.
Marfella R, Gualdiero P, Siniscalchi M, et al: Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension 2003; 41: 237–243.
ALLHAT Collaborative Research Group: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967–1975.
Davis BR, Piller LB, Cutler JA, et al, for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group: Role of diuretics in the prevention of heart failure. Circulation 2006; 113: 2201–2210.
Sica DA : Doxazosin and congestive heart failure. Congest Heart Fail 2002; 8: 178–184.
Kamoi K, Ikarashi T : The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements. Clin Exp Hypertens 2005; 4: 369–376.
Hashimoto J, Chonan K, Aoki Y, et al: Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertens 2003; 21: 805–811.
Nishimura T, Hashimoto J, Ohkubo T, et al: Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Clin Exp Hypertens 2005; 27: 477–489.
Kitahara Y, Saito F, Akao M, et al: Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol 2004; 43: 68–73.
Huupponen R, Lehtonen A, Vahatalo M : Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients. Eur J Clin Pharmacol 1992; 43: 365–868.
Takahashi H, Okabayashi H, Suga K, Matsuzawa M, Ikegaki I, Yoshimura M : Sympatholytic effects of the intravenously injected alpha 1-adrenergic blocker, bunazosin, in anaesthetized rats. J Hypertens 1987; 5: 677–682.
Ikeda T, Gomi T, Shibuya Y, Shinozaki S, Suzuki Y, Matsuda N : Add-on effect of bedtime dosing of the α1-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy. Hypertens Res 2007; 30: 1097–1105.
Marfella R, Siniscalchi M, Nappo F, et al: Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients. Am J Hypertens 2005; 18: 308–318.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, H. New Insights into the Therapeutic Management of Morning Hypertension with α1-Adrenergic Receptor Blockers. Hypertens Res 30, 1011–1013 (2007). https://doi.org/10.1291/hypres.30.1011
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.1011